SCEMBLIX cpr pell 20 mg 60 pce

7680684410017 CH-68441 L01EA06 07.16.

Reimbursement limitations:

SCEMBLIX.01

Asciminib est remboursé pour le traitement de patients adultes atteints de leucémie myéloïde chronique à …

SCEMBLIX cpr pell 20 mg 60 pce
SCEMBLIX cpr pell 20 mg 60 pce
SCEMBLIX cpr pell 20 mg 60 pce
1 / 3
google

Details

Product number
6844101
CPT
-
Packaging group
60
Unit
Tablette(n)
Composition
asciminibum 20 mg ut asciminibi hydrochloridum 21.62 mg, lactosum monohydricum 43.11 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), E 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, E 172 (flavum), E 172 (rubrum), xanthani gummi, pro compresso obducto corresp. natrium max. 0.47 mg.

Articles (1)

Scemblix 20 mg, Filmtabletten
Filmtabletten
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/05/2025
Patient information leaflet
Français
22/05/2025
Patient information leaflet
Italien
22/05/2025
Professional SmPC
Allemand
22/05/2025
Professional SmPC
Français
22/05/2025
Professional SmPC
Italien
22/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
21.62 MG Substance WIZUS
(N/A)
43.11 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 2022.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2023

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
68441
Drug name
Scemblix, Filmtabletten
Galenic form
FILM
ATC Code
L01EA06
Authorization status
Z
Dispensation category
A
First authorization
09/06/2022
Authorization expiration date
08/06/2027
IT number
07.16.
Domain
Human medicine
Field of application
Behandlung von erwachsenen Patienten mit Philadelphia-Chromosom-positiver chronisch-myeloischer Leukämie (Ph+ CML) in der chronischen Phase (CP)

Packaging details

Description (FR)
SCEMBLIX cpr pell 20 mg 60 pce
Description (DE)
SCEMBLIX Filmtabl 20 mg 60 Stk
Market launch
09/06/2022
Narcotic (BTM)
No

Other packaging sizes

SCEMBLIX cpr pell 40 mg 60 pce
60 TABL
GTIN: 7680684410024
View
SCEMBLIX cpr pellic 100 mg 120 pce
120 TABL
GTIN: 7680684410055
View